Standard warm blood aortic root reperfusion showed more favorable outcomes than adenosine-enriched aortic root reperfusion in terms of anti-arrhythmic drug usage, electroshock application, and arrhythmia prevalence among patients undergoing valvular heart surgery.
Key Findings
Results
The adenosine intervention group had a significantly higher rate of antiarrhythmic agent usage in the operating room compared to the control group.
This was a prospective randomized controlled trial with 60 patients total, 30 per group.
The difference in antiarrhythmic agent usage in the operating room reached statistical significance (P < 0.05).
The intervention group received adenosine-enriched aortic root reperfusion immediately prior to aortic declamping.
The control group underwent standard warm blood aortic root reperfusion.
Results
The control group (standard warm blood reperfusion) showed more favorable outcomes in terms of anti-arrhythmic drug usage, electroshock application, and arrhythmia prevalence.
Three outcome measures favored the control group: anti-arrhythmic drug usage, electroshock application, and arrhythmia prevalence.
The study was conducted over a three-month period using a continuous sampling method.
Both groups were matched for demographic and clinical characteristics to ensure comparability.
The paper concludes that standard warm blood aortic root reperfusion has advantages over adenosine-enriched reperfusion in managing post-operative cardiac rhythm disturbances.
Results
There were no significant differences in mean cardiopulmonary bypass (CPB) time, aortic cross-clamping duration, or mechanical ventilation between the intervention and control groups.
CPB time was comparable between the adenosine and standard reperfusion groups.
Aortic cross-clamping duration did not differ significantly between groups.
Duration of mechanical ventilation was similar between groups.
These procedural parameters suggest the groups had similar operative complexity.
Results
Inotropic agent usage was similar in both groups during surgery and in the ICU.
No significant difference in inotropic agent usage was found intraoperatively between the adenosine and control groups.
Inotropic agent usage in the ICU was also comparable between groups.
This suggests adenosine did not provide a measurable benefit in terms of postoperative cardiac contractility support.
Results
Laboratory parameters on the first day of ICU admission were comparable between the adenosine and control groups.
First-day ICU laboratory values did not differ significantly between groups.
This indicates no detectable biochemical advantage or disadvantage associated with adenosine-enriched reperfusion in the immediate postoperative period.
Specific laboratory values measured were not detailed in the abstract.
What This Means
This research examined whether adding adenosine — a naturally occurring molecule with heart-protective properties — to the blood solution used to flush and restart the heart during valve surgery would improve patient outcomes. Sixty patients undergoing valvular heart surgery were randomly divided into two equal groups: one received the adenosine-enriched flush just before the aortic clamp was removed, while the other received the standard warm blood flush. The researchers then compared a range of outcomes including heart rhythm problems, drug use, and time on a breathing machine.
Contrary to what some earlier research had suggested, the adenosine group did not show better outcomes. In fact, patients who received adenosine required more anti-arrhythmia medications in the operating room, experienced more electroshock treatments, and had a higher prevalence of arrhythmias (irregular heart rhythms) compared to the standard treatment group. Other measures — such as time on the bypass machine, time with the aorta clamped, ventilator use, need for drugs to support heart pumping, and lab test results — were similar between the two groups.
This research suggests that the standard warm blood aortic root reperfusion technique may be preferable to adenosine-enriched reperfusion for managing heart rhythm disturbances after valvular heart surgery. The findings add to ongoing uncertainty about when and how adenosine should be used in cardiac surgery, and highlight the need for further research given the small sample size (30 patients per group) and short study duration of three months.
Jalili Shahandashti F, Kachoueian N, Fattahi M, Samaie D, Ghanbari Garekani M, Taherkhani A, et al.. (2026). Impact of adenosine in controlled aortic root reperfusion on clinical outcomes among patients undergoing valvular heart surgery.. The journal of extra-corporeal technology. https://doi.org/10.1051/ject/2026006